ReP USP - Resultado da busca

Artigo de periodico
Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparison of ponatinib versus imatinib (2025)
Ashaye, Ajibade; Shi, Ling; Aldoss, Ibrahim; Montesinos, Pau; Vachhani, Pankit; Rocha, Vanderson Geraldo ; Papayannidis, Cristina; Leonard, Jessica T; Baer, Maria R; Ribera, Jose-Maria
Source: Cancer medicine. Unidade: FM
Subjects: LEUCEMIA MIELOIDE AGUDA, SINAIS E SINTOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASHAYE, Ajibade et al. Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparison of ponatinib versus imatinib. Cancer medicine, v. 14, n. 7, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/84773. Acesso em: 10 fev. 2026.
APA
Ashaye, A., Shi, L., Aldoss, I., Montesinos, P., Vachhani, P., Rocha, V. G., et al. (2025). Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparison of ponatinib versus imatinib. Cancer medicine, 14( 7). doi:10.1002/cam4.70780
NLM
Ashaye A, Shi L, Aldoss I, Montesinos P, Vachhani P, Rocha VG, Papayannidis C, Leonard JT, Baer MR, Ribera J-M. Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparison of ponatinib versus imatinib [Internet]. Cancer medicine. 2025 ; 14( 7):[citado 2026 fev. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84773
Vancouver
Ashaye A, Shi L, Aldoss I, Montesinos P, Vachhani P, Rocha VG, Papayannidis C, Leonard JT, Baer MR, Ribera J-M. Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparison of ponatinib versus imatinib [Internet]. Cancer medicine. 2025 ; 14( 7):[citado 2026 fev. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84773
Artigo de periodico
Retinoblastoma treatment in a Brazilian population.: presentation and long-term results (2024)
Bonanomi, Maria Teresa Brizzi Chizzotti; Almeida, Maria Tereza A. de; Hollaender, Marianna A.; Bonanomi, Roberta Chizzotti; Monteiro, Mario Luiz Ribeiro
Source: Cancer medicine. Unidade: FM
Subjects: RETINOBLASTOMA, RESULTADO DE TRATAMENTO, BRASILEIROS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONANOMI, Maria Teresa Brizzi Chizzotti et al. Retinoblastoma treatment in a Brazilian population.: presentation and long-term results. Cancer medicine, v. 13, n. 3, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58927. Acesso em: 10 fev. 2026.
APA
Bonanomi, M. T. B. C., Almeida, M. T. A. de, Hollaender, M. A., Bonanomi, R. C., & Monteiro, M. L. R. (2024). Retinoblastoma treatment in a Brazilian population.: presentation and long-term results. Cancer medicine, 13( 3). doi:10.1002/cam4.6683
NLM
Bonanomi MTBC, Almeida MTA de, Hollaender MA, Bonanomi RC, Monteiro MLR. Retinoblastoma treatment in a Brazilian population.: presentation and long-term results [Internet]. Cancer medicine. 2024 ; 13( 3):[citado 2026 fev. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58927
Vancouver
Bonanomi MTBC, Almeida MTA de, Hollaender MA, Bonanomi RC, Monteiro MLR. Retinoblastoma treatment in a Brazilian population.: presentation and long-term results [Internet]. Cancer medicine. 2024 ; 13( 3):[citado 2026 fev. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58927
Artigo de periodico
Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: a Medicare SEER cohort analysis (2021)
Balkrishnan, Rajesh; Desai, Raj P.; Narayan, Aditya; Camacho, Fabian T.; Flausino, Lucas E.; Chammas, Roger
Source: Cancer medicine. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS, ESTUDOS DE COORTES, MORTALIDADE, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALKRISHNAN, Rajesh et al. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: a Medicare SEER cohort analysis. Cancer medicine, v. 10, n. 15, p. 5347-5357, 2021Tradução . . Disponível em: https://doi.org/10.1002/cam4.4088. Acesso em: 10 fev. 2026.
APA
Balkrishnan, R., Desai, R. P., Narayan, A., Camacho, F. T., Flausino, L. E., & Chammas, R. (2021). Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: a Medicare SEER cohort analysis. Cancer medicine, 10( 15), 5347-5357. doi:10.1002/cam4.4088
NLM
Balkrishnan R, Desai RP, Narayan A, Camacho FT, Flausino LE, Chammas R. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: a Medicare SEER cohort analysis [Internet]. Cancer medicine. 2021 ; 10( 15): 5347-5357.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1002/cam4.4088
Vancouver
Balkrishnan R, Desai RP, Narayan A, Camacho FT, Flausino LE, Chammas R. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: a Medicare SEER cohort analysis [Internet]. Cancer medicine. 2021 ; 10( 15): 5347-5357.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1002/cam4.4088
Artigo de periodico
An integrative histopathologic clustering model based on immuno-matrix elements to predict the risk of death in malignant mesothelioma (2020)
Balancin, Marcelo Luiz ; Teodoro, Walcy Paganelli Rosolia ; Farhat, Cecilia; Miranda, Tomas Jurandir de; Assato, Aline Kawassaki; Silva, Neila Aparecida de Souza; Velosa, Ana Paula; Falzoni, Roberto; Ab'saber, Alexandre Muxfeldt; Roden, Anja C.; Capelozzi, Vera Luiza
Source: Cancer medicine. Unidade: FM
Subjects: ANÁLISE DE CONGLOMERADOS, AUTOIMUNIDADE, BIOMARCADORES, CARCINOGÊNESE, COLÁGENO, LINFÓCITOS, MATRIZ EXTRACELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALANCIN, Marcelo Luiz et al. An integrative histopathologic clustering model based on immuno-matrix elements to predict the risk of death in malignant mesothelioma. Cancer medicine, v. 9, n. 13, p. 4836-4849, 2020Tradução . . Disponível em: https://doi.org/10.1002/cam4.3111. Acesso em: 10 fev. 2026.
APA
Balancin, M. L., Teodoro, W. P. R., Farhat, C., Miranda, T. J. de, Assato, A. K., Silva, N. A. de S., et al. (2020). An integrative histopathologic clustering model based on immuno-matrix elements to predict the risk of death in malignant mesothelioma. Cancer medicine, 9( 13), 4836-4849. doi:10.1002/cam4.3111
NLM
Balancin ML, Teodoro WPR, Farhat C, Miranda TJ de, Assato AK, Silva NA de S, Velosa AP, Falzoni R, Ab'saber AM, Roden AC, Capelozzi VL. An integrative histopathologic clustering model based on immuno-matrix elements to predict the risk of death in malignant mesothelioma [Internet]. Cancer medicine. 2020 ; 9( 13): 4836-4849.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1002/cam4.3111
Vancouver
Balancin ML, Teodoro WPR, Farhat C, Miranda TJ de, Assato AK, Silva NA de S, Velosa AP, Falzoni R, Ab'saber AM, Roden AC, Capelozzi VL. An integrative histopathologic clustering model based on immuno-matrix elements to predict the risk of death in malignant mesothelioma [Internet]. Cancer medicine. 2020 ; 9( 13): 4836-4849.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1002/cam4.3111
Artigo de periodico
Performance of the UroVysion (R) FISH assay for the diagnosis of malignant effusions using two cutoff strategies (2018)
Rosolen, Debora C. B.; Antonangelo, Leila
Source: Cancer medicine. Unidade: FM
Subjects: NEOPLASIAS, DERRAME PLEURAL, REAÇÃO EM CADEIA POR POLIMERASE, CITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSOLEN, Debora C. B. e ANTONANGELO, Leila. Performance of the UroVysion (R) FISH assay for the diagnosis of malignant effusions using two cutoff strategies. Cancer medicine, v. 7, n. 5, p. 1967-1977, 2018Tradução . . Disponível em: https://doi.org/10.1002/cam4.1442. Acesso em: 10 fev. 2026.
APA
Rosolen, D. C. B., & Antonangelo, L. (2018). Performance of the UroVysion (R) FISH assay for the diagnosis of malignant effusions using two cutoff strategies. Cancer medicine, 7( 5), 1967-1977. doi:10.1002/cam4.1442
NLM
Rosolen DCB, Antonangelo L. Performance of the UroVysion (R) FISH assay for the diagnosis of malignant effusions using two cutoff strategies [Internet]. Cancer medicine. 2018 ; 7( 5): 1967-1977.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1002/cam4.1442
Vancouver
Rosolen DCB, Antonangelo L. Performance of the UroVysion (R) FISH assay for the diagnosis of malignant effusions using two cutoff strategies [Internet]. Cancer medicine. 2018 ; 7( 5): 1967-1977.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1002/cam4.1442

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies